These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16963274

  • 1. The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation.
    Ramakers BP, Riksen NP, Rongen GA, van der Hoeven JG, Smits P, Pickkers P.
    Cytokine; 2006 Jul; 35(1-2):95-9. PubMed ID: 16963274
    [Abstract] [Full Text] [Related]

  • 2. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
    Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, Chung KF.
    J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
    [Abstract] [Full Text] [Related]

  • 3. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK, Mickelson DJ, Fink J, Solberg JC, Inglefield JR, Hook D, Gupta SK, Gibson S, Alkan SS.
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [Abstract] [Full Text] [Related]

  • 4. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
    Ghosh TK, Mickelson DJ, Solberg JC, Lipson KE, Inglefield JR, Alkan SS.
    Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
    [Abstract] [Full Text] [Related]

  • 5. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC, Moore JN, Hurley DJ, Vandenplas ML, Linden J, Cao Z, Murray TF.
    Vet Immunol Immunopathol; 2008 Jan 15; 121(1-2):91-100. PubMed ID: 17913243
    [Abstract] [Full Text] [Related]

  • 6. Adenosine inhibits the release of interleukin-1beta in activated human peripheral mononuclear cells.
    Sipka S, Kovács I, Szántó S, Szegedi G, Brugós L, Bruckner G, József Szentmiklósi A.
    Cytokine; 2005 Aug 21; 31(4):258-63. PubMed ID: 16026998
    [Abstract] [Full Text] [Related]

  • 7. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K.
    Int Immunol; 2007 Mar 21; 19(3):311-20. PubMed ID: 17289654
    [Abstract] [Full Text] [Related]

  • 8. Human monocytoid cells as a model to study Toll-like receptor-mediated activation.
    Remer KA, Brcic M, Sauter KS, Jungi TW.
    J Immunol Methods; 2006 Jun 30; 313(1-2):1-10. PubMed ID: 16720029
    [Abstract] [Full Text] [Related]

  • 9. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
    de Vos AF, Pater JM, van den Pangaart PS, de Kruif MD, van 't Veer C, van der Poll T.
    J Immunol; 2009 Jul 01; 183(1):533-42. PubMed ID: 19542464
    [Abstract] [Full Text] [Related]

  • 10. Evidence for dissociation of TLR mRNA expression and TLR agonist-mediated functions in bovine macrophages.
    Franchini M, Schweizer M, Mätzener P, Magkouras I, Sauter KS, Mirkovitch J, Peterhans E, Jungi TW.
    Vet Immunol Immunopathol; 2006 Mar 15; 110(1-2):37-49. PubMed ID: 16216336
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of in vitro tumor cell proliferation by cytokines induced by combinations of TLR or TLR and TCR agonists.
    Ghosh TK, Mickelson DJ, Lipson KE, Alkan SS.
    Int Immunopharmacol; 2007 Nov 15; 7(11):1471-82. PubMed ID: 17761351
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors.
    Weaver LK, Pioli PA, Wardwell K, Vogel SN, Guyre PM.
    J Leukoc Biol; 2007 Mar 15; 81(3):663-71. PubMed ID: 17164428
    [Abstract] [Full Text] [Related]

  • 13. Menstrual cycle influences Toll-like receptor responses.
    Dennison U, McKernan DP, Scully P, Clarke G, Cryan J, Dinan T.
    Neuroimmunomodulation; 2012 Mar 15; 19(3):171-9. PubMed ID: 22262081
    [Abstract] [Full Text] [Related]

  • 14. Differential regulatory effects of adenosine on cytokine release by activated human monocytes.
    Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA.
    J Immunol; 1994 Nov 01; 153(9):4159-68. PubMed ID: 7930619
    [Abstract] [Full Text] [Related]

  • 15. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA).
    Roelofs MF, Wenink MH, Brentano F, Abdollahi-Roodsaz S, Oppers-Walgreen B, Barrera P, van Riel PL, Joosten LA, Kyburz D, van den Berg WB, Radstake TR.
    Ann Rheum Dis; 2009 Sep 01; 68(9):1486-93. PubMed ID: 18765427
    [Abstract] [Full Text] [Related]

  • 16. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO, Cho ML, Lee SY, Oh HJ, Park JS, Park MK, Park MJ, Ju JH, Kim SI, Park SH, Kim HY, Min JK.
    Immunol Lett; 2009 Apr 27; 123(2):138-43. PubMed ID: 19428561
    [Abstract] [Full Text] [Related]

  • 17. Expression profiles and function of Toll-like receptors in human corneal epithelia.
    Wu XY, Gao JL, Ren MY.
    Chin Med J (Engl); 2007 May 20; 120(10):893-7. PubMed ID: 17543179
    [Abstract] [Full Text] [Related]

  • 18. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
    Krumbiegel D, Zepp F, Meyer CU.
    Hum Immunol; 2007 Oct 20; 68(10):813-22. PubMed ID: 17961769
    [Abstract] [Full Text] [Related]

  • 19. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation.
    Kox M, van Velzen JF, Pompe JC, Hoedemaekers CW, van der Hoeven JG, Pickkers P.
    Biochem Pharmacol; 2009 Oct 01; 78(7):863-72. PubMed ID: 19576181
    [Abstract] [Full Text] [Related]

  • 20. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K, Sunk IG, Hofstaetter JG, Amoyo L, Toma CD, Akira S, Weichhart T, Saemann M, Smolen JS.
    Arthritis Rheum; 2007 Jun 01; 56(6):1880-93. PubMed ID: 17530716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.